LENZ Therapeutics, Inc. (NASDAQ:LENZ) Shares Sold by Geode …

Jan 3, 2025 · Geode Capital Management LLC lowered its position in LENZ Therapeutics, Inc. (NASDAQ:LENZ - Free Report) by 6.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission.The firm owned 338,024 …

1%
OFF

LENZ Therapeutics, Inc. (NASDAQ:LENZ) Shares Sold By Geode …

2 weeks from now

marketbeat.com

23%
OFF

LENZ Therapeutics, Inc. (NASDAQ:LENZ) Shares Sold By Geode …

2 weeks from now

Jan 3, 2025 · The firm owned 338,024 shares of the company’s stock after selling 22,096 shares during the period. Geode Capital Management LLC owned about 1.23% of LENZ Therapeutics …

defenseworld.net

0%
OFF

Geode Capital Management LLC Sells 25,287 Shares Of Aerovate ...

2 weeks from now

3 days ago · Geode Capital Management LLC cut its holdings in Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Free Report) by 8.0% in the 3rd quarter, according to the company in its …

etfdailynews.com

$343000
OFF

Geode Capital Management LLC Invests $343,000 In Oruka …

2 weeks from now

2 days ago · Geode Capital Management LLC Sells 6,258 Shares of TELUS International (Cda) Inc. (NYSE:TIXT) Geode Capital Management LLC Has $329,000 Stock Position in BM …

etfdailynews.com

7%
OFF

LENZ LENZ Therapeutics Stock Data, Filings, Earnings, News

2 weeks from now

Shares Value Change; Ra Capital Management: 4.18 mm: $72.25 bn-1.7% ... Geode Capital Management: 360.12 k +360.12 k: NEW: Alyeska Investment: 321.72 k ... Why LENZ …

capedge.com

$1
OFF

How To Find The Value Of Your Old Stock Certificates

2 weeks from now

0.5 share Common $1 par. Bowser Inc. (IN) reincorporated in Delaware as Bowser Delaware 11/17/69" Any reference to "Capital Stock" essentially means shares held in the company. So …

instructables.com

FAQs about LENZ Therapeutics, Inc. (NASDAQ:LENZ) Shares Sold by Geode … Coupon?

Does Charles Schwab own Lenz Therapeutics?

Charles Schwab Investment Management Inc. raised its stake in shares of LENZ Therapeutics by 197.5% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 123,371 shares of the company’s stock valued at $2,929,000 after acquiring an additional 81,901 shares during the period. ...

Does state Street own Lenz Therapeutics?

State Street Corp lifted its holdings in shares of LENZ Therapeutics by 18.7% during the 3rd quarter. State Street Corp now owns 289,154 shares of the company’s stock valued at $6,865,000 after acquiring an additional 45,600 shares in the last quarter. ...

What is the price of Lenz Therapeutics (Lenz) stock?

Shares of NASDAQ LENZ opened at $28.29 on Friday. LENZ Therapeutics, Inc. has a 1 year low of $14.42 and a 1 year high of $38.93. The stock’s 50-day simple moving average is $32.46 and its 200-day simple moving average is $25.80. LENZ Therapeutics (NASDAQ:LENZ – Get Free Report) last posted its quarterly earnings data on Wednesday, November 6th. ...

Does Parkman healthcare partners own Lenz Therapeutics?

Parkman Healthcare Partners LLC acquired a new position in LENZ Therapeutics during the third quarter valued at approximately $3,308,000. Charles Schwab Investment Management Inc. raised its stake in shares of LENZ Therapeutics by 197.5% in the 3rd quarter. ...

Is Lenz a biopharmaceutical company?

(Free Report) LENZ Therapeutics, Inc, a biopharmaceutical company, focuses on developing and commercializing therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. The company is headquartered in Del Mar, California. ...